We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$35.2B
AUM Growth
+$788M
Cap. Flow
-$64.4M
Cap. Flow %
-0.18%
Top 10 Hldgs %
30.09%
Holding
5,577
New
1,148
Increased
1,513
Reduced
1,639
Closed
1,253

Sector Composition

Rank Sector Weight
1 Technology 1.2%
2 Consumer Discretionary 1.19%
3 Communication Services 0.68%
4 Financials 0.67%
5 Healthcare 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UEC icon
4301
CALL
Uranium Energy
UEC
$4.67B
$15K ﹤0.01%
+10,700
New +$14.7K
KA
4302
PUT
DELISTED
Kineta, Inc. Common Stock
KA
$14K ﹤0.01%
103
-78
-43% -$12.1K
DMK
4303
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$14K ﹤0.01%
157
-70
-31% -$8.51K
LCTX icon
4304
PUT
Lineage Cell Therapeutics
LCTX
$267M
$12K ﹤0.01%
10,500
-7,900
-43% -$9.1K
FGP
4305
CALL
DELISTED
Ferrellgas Partners, L.P.
FGP
$12K ﹤0.01%
12,900
-9,800
-43% -$11.5K
CTIC
4306
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$12K ﹤0.01%
13,600
+1,100
+9% +$1.01K
ALTO icon
4307
CALL
Alto Ingredients
ALTO
$345M
$11K ﹤0.01%
+13,900
New +$14.2K
GSAT icon
4308
PUT
Globalstar
GSAT
$10.2B
$11K ﹤0.01%
1,473
+93
+7% +$728
FRTX
4309
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$11K ﹤0.01%
+40
New +$13.4K
ENT
4310
DELISTED
Global Eagle Entertainment Inc.
ENT
$11K ﹤0.01%
+650
New +$11.7K
ASNA
4311
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
$11K ﹤0.01%
880
+260
+42% +$5.52K
ALTO icon
4312
PUT
Alto Ingredients
ALTO
$345M
$10K ﹤0.01%
13,200
-7,700
-37% -$7.86K
HDSN
4313
Hudson Technologies
HDSN
$259M
$10K ﹤0.01%
+11,896
New +$18.9K
GSAT icon
4314
CALL
Globalstar
GSAT
$10.2B
$9K ﹤0.01%
1,300
-1,287
-50% -$10.1K
AVEO
4315
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$9K ﹤0.01%
+1,385
New +$11.9K
ASNA
4316
CALL
DELISTED
Ascena Retail Group, Inc.
ASNA
$9K ﹤0.01%
775
-525
-40% -$11.1K
ALTO icon
4317
Alto Ingredients
ALTO
$345M
$8K ﹤0.01%
10,839
-14,122
-57% -$14.4K
HSTO
4318
PUT
DELISTED
Histogen Inc. Common Stock
HSTO
$8K ﹤0.01%
+155
New +$26.9K
AMPE
4319
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7K ﹤0.01%
60
+20
+50% +$3.17K
HSTO
4320
DELISTED
Histogen Inc. Common Stock
HSTO
$7K ﹤0.01%
+134
New +$23.3K
AMPE
4321
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
+49
New +$7.76K
AAXJ icon
4322
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.58B
-4,800
Closed -$339K
ABEV icon
4323
CALL
Ambev
ABEV
$48.4B
-21,000
Closed -$90K
ABEV icon
4324
Ambev
ABEV
$48.4B
-18,548
Closed -$80K
ABG icon
4325
CALL
Asbury Automotive
ABG
$4.49B
-4,800
Closed -$333K

Similar funds

Wolverine Trading's Q2 2019 Portfolio in Review

As of Q2 2019, Wolverine Trading held 5,577 positions worth $35.2B, up 2.3% from $34.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Wolverine Trading's Q2 2019 filing shows 1,148 new, 1,513 increased, 1,639 reduced and 1,253 closed positions. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 21,298 shares worth $35.4M. The largest sale was Invesco QQQ Trust, an estimated $322M.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, up from 0.87% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Wolverine Trading's largest Q2 2019 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 21,298 shares worth $35.4M.
  • Wolverine Trading added most to Alphabet (Google) Class A in Q2 2019, an estimated $47.4M increase.
  • Wolverine Trading's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $322M.
  • Wolverine Trading fully exited Invesco DB Gold Fund in Q2 2019, selling an estimated $41.9M.
  • Wolverine Trading's ten largest holdings make up 30% of its $35.2B portfolio in Q2 2019.
  • Wolverine Trading opened 1,148 new positions and closed 1,253 in Q2 2019.
  • Wolverine Trading's portfolio value rose 2.3% quarter-over-quarter to $35.2B.

Based on Wolverine Trading's 13F filing for Q2 2019, filed 20 Aug 2019.